SINOPHARM GROUP 1/5/O.N. Working Capital to Net Assets Ratio
SINOPHARM GROUP 1/5/O.N. working capital to net assets ratio. SINOPHARM GROUP 1/5/O.N. (X2S1) has a Working Capital to Net Assets ratio of 74.6% as of December 2025. Working capital of €100.07 Billion (current assets of €346.80 Billion minus current liabilities of €246.73 Billion) is measured against net assets of €134.16 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check X2S1 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of SINOPHARM GROUP 1/5/O.N. (2021–2025)
Working capital to net assets ratio of SINOPHARM GROUP 1/5/O.N. from 2021 to 2025. This chart shows how SINOPHARM GROUP 1/5/O.N.'s Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 74.6%, reflecting working capital of €100.07 Billion against net assets of €134.16 Billion EUR. See defensive interval ratio of SINOPHARM GROUP 1/5/O.N. to measure how many days the company can operate on defensive assets alone.
SINOPHARM GROUP 1/5/O.N. Working Capital to Net Assets Ratio by Year (2021–2025)
SINOPHARM GROUP 1/5/O.N. working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for SINOPHARM GROUP 1/5/O.N. from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see X2S1 asset base.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 74.6% | €100.07 Billion | €134.16 Billion | €346.80 Billion | €246.73 Billion | ▼ -2.0 pp |
| 2024 | 76.6% | €97.07 Billion | €126.69 Billion | €347.45 Billion | €250.38 Billion | ▼ -2.6 pp |
| 2023 | 79.2% | €95.34 Billion | €120.32 Billion | €336.84 Billion | €241.49 Billion | ▲ +2.5 pp |
| 2022 | 76.7% | €84.44 Billion | €110.07 Billion | €319.41 Billion | €234.96 Billion | ▲ +4.9 pp |
| 2021 | 71.9% | €71.62 Billion | €99.65 Billion | €290.92 Billion | €219.31 Billion | — |